JP2010519180A5 - - Google Patents

Download PDF

Info

Publication number
JP2010519180A5
JP2010519180A5 JP2009546652A JP2009546652A JP2010519180A5 JP 2010519180 A5 JP2010519180 A5 JP 2010519180A5 JP 2009546652 A JP2009546652 A JP 2009546652A JP 2009546652 A JP2009546652 A JP 2009546652A JP 2010519180 A5 JP2010519180 A5 JP 2010519180A5
Authority
JP
Japan
Prior art keywords
molecule
disease
moshiku
crohn
plasma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009546652A
Other languages
English (en)
Japanese (ja)
Other versions
JP5603083B2 (ja
JP2010519180A (ja
Filing date
Publication date
Priority claimed from EP07090010A external-priority patent/EP1950222A1/de
Priority claimed from DE200710004909 external-priority patent/DE102007004909A1/de
Application filed filed Critical
Priority claimed from PCT/DE2008/000183 external-priority patent/WO2008089756A2/de
Publication of JP2010519180A publication Critical patent/JP2010519180A/ja
Publication of JP2010519180A5 publication Critical patent/JP2010519180A5/ja
Application granted granted Critical
Publication of JP5603083B2 publication Critical patent/JP5603083B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009546652A 2007-01-26 2008-01-28 炎症性大腸炎及び慢性膵炎の診断のために、膵臓の酵素原顆粒由来の糖タンパク質２（ｇｐ２）との免疫反応を介して体液から抗体を検出する方法 Active JP5603083B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP07090010.5 2007-01-26
EP07090010A EP1950222A1 (de) 2007-01-26 2007-01-26 Verfahren zum Nachweis von Antikörpern aus Körperflüssigkeiten durch eine Immunreaktion mit Glykoprotein 2 (GP2) aus zymogenen Granula des Pankreas zur Differentialdiagnose von entzündlichen Darmerkrankungen und chronischer Pankreatitis
DE200710004909 DE102007004909A1 (de) 2007-01-26 2007-01-26 Verfahren zum Nachweis von Antikörpern aus Körperflüssigkeiten durch eine Immunreaktion mit Glykoprotein 2(GP2) aus zymogenen Granula des Pankreas zur Differentialdiagnose von entzündlichen Darmerkrankungen und chronischer Pankreatitis
DE102007004909.0 2007-01-26
PCT/DE2008/000183 WO2008089756A2 (de) 2007-01-26 2008-01-28 Verfahren zum nachweis von antikörpern aus körperflüssigkeiten durch eine immunreaktion mit glykoprotein 2 (gp2) aus zymogenen granula des pankreas zur differentialdiagnose von entzündlichen darmerkrankungen und chronischer pankreatitis

Publications (3)

Publication Number Publication Date
JP2010519180A JP2010519180A (ja) 2010-06-03
JP2010519180A5 true JP2010519180A5 (enExample) 2012-01-12
JP5603083B2 JP5603083B2 (ja) 2014-10-08

Family

ID=39644915

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009546652A Active JP5603083B2 (ja) 2007-01-26 2008-01-28 炎症性大腸炎及び慢性膵炎の診断のために、膵臓の酵素原顆粒由来の糖タンパク質２（ｇｐ２）との免疫反応を介して体液から抗体を検出する方法

Country Status (13)

Country Link
US (1) US8058019B2 (enExample)
EP (1) EP2126582B1 (enExample)
JP (1) JP5603083B2 (enExample)
KR (1) KR101283710B1 (enExample)
CN (1) CN101611320B (enExample)
AT (1) ATE515704T1 (enExample)
AU (1) AU2008209176B2 (enExample)
CA (1) CA2674021C (enExample)
DK (1) DK2126582T3 (enExample)
ES (1) ES2369544T3 (enExample)
PL (1) PL2126582T3 (enExample)
PT (1) PT2126582E (enExample)
WO (1) WO2008089756A2 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7195759B2 (en) * 2001-06-06 2007-03-27 The University Of Manitoba Therapeutic uses of glandular kallikrein
GB0905076D0 (en) * 2009-03-24 2009-05-06 Total Scient Ltd Diagnostic kits and methods
EP2521915A4 (en) * 2010-01-04 2013-05-29 Mayo Foundation PERIPHERINE-SPECIFIC AUTOANTIKÖRPER AS A MARKER FOR NEUROLOGICAL AND ENDOCRINOLOGICAL DISEASES
US20130315891A1 (en) 2012-05-25 2013-11-28 Matthew Charles Formulations of human tissue kallikrein-1 for parenteral delivery and related methods
US20130323222A1 (en) 2012-06-04 2013-12-05 Matthew Charles Human tissue kallikrein 1 glycosylation isoforms
US11340235B2 (en) * 2014-02-28 2022-05-24 Ga Generic Assays Gmbh GP2 isoforms and their use in autoantibody capture
EP2913675B1 (en) 2014-02-28 2020-02-12 GA Generic Assays GmbH GP2 isoforms and their use in autoantibody capture
EP3299818B1 (en) * 2016-09-26 2019-12-04 GA Generic Assays GmbH Method for the diagnosis of acute pancreatitis (ap) by detection of glycoprotein 2 isoform alpha (gp2a)
CN110073217A (zh) * 2016-10-04 2019-07-30 豪夫迈·罗氏有限公司 用于鉴定合成分类器的系统和方法
AU2018230478B2 (en) 2017-03-09 2025-01-23 Diamedica Inc. Dosage forms of tissue kallikrein 1
EP3477300A1 (de) * 2017-10-25 2019-05-01 Euroimmun Medizinische Labordiagnostika AG Zellulose-basierter immunadsorber
US20220331357A1 (en) * 2019-09-27 2022-10-20 Duke University Compositions and methods for the prevention and treatment of pancreatitis
CN110806485A (zh) * 2019-11-12 2020-02-18 广州医科大学附属第二医院 一种胶质纤维酸性蛋白抗体检测试剂盒及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5663315A (en) 1994-12-06 1997-09-02 Alphagene, Inc. Isolated DNA encoding human GP2
DE19630557C2 (de) * 1996-07-18 1998-07-02 Schuppan Detlef Priv Doz Dr Dr Verfahren zum Nachweis von Antikörpern aus Körperflüssigkeiten durch eine Immunreaktion mit Gewebe-Transglutaminase (tTG) sowie die Verwendung von tTG in Diagnose und Therapie
US6100098A (en) * 1997-02-18 2000-08-08 Mcgill University Anti-AGE IgG and uses thereof for the diagnosis of severe disease
AU2001271284A1 (en) 2000-06-07 2001-12-17 Corixa Corporation Compositions and methods for the therapy and diagnosis of pancreatic cancer
JP2004005319A (ja) 2002-04-24 2004-01-08 Japan Science & Technology Corp 遺伝子データベース作成方法、遺伝子データベース作成装置、遺伝子データベース作成プログラム、および遺伝子データベース作成プログラムを記録したコンピュータ読み取り可能な記録媒体
US20070275422A1 (en) 2004-07-26 2007-11-29 The Board Of Trustees Of The Leland Stanford Jr. U Methods and Compositions for Detecting Pancreatic Disease

Similar Documents

Publication Publication Date Title
JP2010519180A5 (enExample)
US11141460B2 (en) Methods for treatment of bile acid-related disorders and prediction of clinical sensitivity to treatment of bile acid-related disorders
KR102724421B1 (ko) 담즙산 항상성의 조절 및 담즙산 질환 및 질병의 치료 방법
JP2019533807A5 (enExample)
JP2020073528A (ja) 肺高血圧症を治療するための組成物および方法
JP6728352B2 (ja) 胆汁酸に関係した障害の治療方法
JP2010229138A5 (enExample)
CN109311983B (zh) 人源化抗clever-1抗体及其用途
NO990190L (no) Immunologisk fremgangsmÕte for pÕvisning av antistoffer rettet mot vevstransglutaminase (TTG), anvendelse av TTG for diagnostiske formÕl og terapikontroll og oralt farmas°ytisk middel inneholdende TTG
AU2015277438A1 (en) Methods and uses for modulating bile acid homeostasis and treatment of bile acid disorders and diseases
JP2006524034A5 (enExample)
JP2009544284A5 (enExample)
JP2013508719A5 (enExample)
JP2013178260A5 (enExample)
JP2010501594A5 (enExample)
JP2008508861A5 (enExample)
JP2021529828A5 (enExample)
JP4313433B2 (ja) イミュノグロブリン結合能を有するペプチド
JP2017523130A5 (enExample)
EP2383336A1 (en) Peptide capable of binding to immunoglobulin
JPH02479A (ja) ｓｎＲＮＰ−Ａ抗原及びそのフラグメント
CN104619333A (zh) 经修饰的肽,cb受体的配体,用于评估与cb受体结合的试剂盒、体外方法,用于调节cb受体活性的药物组合物、用途
WO2020146610A1 (en) Harnessing inflammation to treat neurodevelopmental disorders
US20150335763A1 (en) Hmgb1-binding beads and uses thereof
WO2018156645A1 (en) Preventative cancer therapy